When is lung lobectomy recommended for non-small cell lung cancer?

A lobectomy removes the affected lobe rather than the whole lung. The surgeon also assesses nearby lymph nodes, which can help clarify the extent of disease and guide further treatment. This approach is considered during a team review of scans, biopsy findings, tumour position and whether the cancer can be removed with clear margins. Lung function tests, heart health, fitness, other illnesses and previous treatments help determine whether recovery is likely to be manageable.

It is not suitable for every tumour or every person. A smaller operation, a different cancer treatment, or removal of more lung tissue may be discussed when the tumour's size, position or spread calls for another plan.

Ask the thoracic surgery team how the tumour's location affects the proposed operation and what tests are needed before a decision. Bring a list of medicines, smoking or vaping history, breathing symptoms and previous chest procedures. Preoperative breathing assessment, medication review and a plan for movement after surgery can support safer recovery. The team can also explain hospital stay expectations, pain control, breathing exercises and when other treatments may be added.

Contact your cancer team promptly for new or worsening breathlessness, chest pain, coughing blood, fever, confusion or a sudden fall in strength. After surgery, urgent assessment is appropriate for severe breathing difficulty, blue lips, fainting, uncontrolled pain or heavy bleeding from a wound. These symptoms need assessment because they can reflect a postoperative problem or a change requiring treatment.

Could a lobectomy remove all visible disease in my case? Which scan and biopsy findings support this recommendation? How will my breathing tests affect the plan? What alternatives should I compare, and how would lymph-node findings change treatment afterward?